Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease (Q40390092)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease |
scientific article |
Statements
1 reference
Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease (English)
1 reference
Hirokazu Kanegane
1 reference
Keiichi Hirono
1 reference
Yasushi Kemmotsu
1 reference
Helmut Wittkowski
1 reference
Dirk Foell
1 reference
Kazuyoshi Saito
1 reference
Keijirou Ibuki
1 reference
Kazuhiro Watanabe
1 reference
Sayaka Watanabe
1 reference
Keiichirou Uese
1 reference
Hideki Origasa
1 reference
Fukiko Ichida
1 reference
Johhanes Roth
1 reference
Toshio Miyawaki
1 reference
Tsutomu Saji
1 reference
1 June 2009
1 reference
1 reference
65
1 reference
6
1 reference
696-701
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference